Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, Status and Forecast 2020-2026

Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Off-Label
1.4.3 Therapeutic
1.5 Market by Application
1.5.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Online Provider
1.5.4 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Perspective (2015-2026)
2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Growth Trends by Regions
2.2.1 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Alcoholic Steatohepatitis (NASH) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Market Size
3.1.1 Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Revenue (2015-2020)
3.1.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio
3.2.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2019
3.3 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players Head office and Area Served
3.4 Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Product Solution and Service
3.5 Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Type (2021-2026)
5 Non-Alcoholic Steatohepatitis (NASH) Treatment Breakdown Data by Application (2015-2026)
5.1 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
5.2 Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
6.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in North America (2019-2020)
6.3 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
6.4 North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
7.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in Europe (2019-2020)
7.3 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
7.4 Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
8.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in China (2019-2020)
8.3 China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
8.4 China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
9.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in Japan (2019-2020)
9.3 Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
9.4 Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
10.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
11.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in India (2019-2020)
11.3 India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
11.4 India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size (2015-2020)
12.2 Non-Alcoholic Steatohepatitis (NASH) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan Plc (Tobira)
13.1.1 Allergan Plc (Tobira) Company Details
13.1.2 Allergan Plc (Tobira) Business Overview and Its Total Revenue
13.1.3 Allergan Plc (Tobira) Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.1.4 Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020))
13.1.5 Allergan Plc (Tobira) Recent Development
13.2 Bristol Myers Squibb
13.2.1 Bristol Myers Squibb Company Details
13.2.2 Bristol Myers Squibb Business Overview and Its Total Revenue
13.2.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.2.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
13.2.5 Bristol Myers Squibb Recent Development
13.3 Galmed Pharmaceuticals
13.3.1 Galmed Pharmaceuticals Company Details
13.3.2 Galmed Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.3.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
13.3.5 Galmed Pharmaceuticals Recent Development
13.4 Genfit SA
13.4.1 Genfit SA Company Details
13.4.2 Genfit SA Business Overview and Its Total Revenue
13.4.3 Genfit SA Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.4.4 Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
13.4.5 Genfit SA Recent Development
13.5 Gilead Sciences, Inc.
13.5.1 Gilead Sciences, Inc. Company Details
13.5.2 Gilead Sciences, Inc. Business Overview and Its Total Revenue
13.5.3 Gilead Sciences, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.5.4 Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
13.5.5 Gilead Sciences, Inc. Recent Development
13.6 Intercept Pharmaceuticals, Inc.
13.6.1 Intercept Pharmaceuticals, Inc. Company Details
13.6.2 Intercept Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.6.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.6.4 Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
13.6.5 Intercept Pharmaceuticals, Inc. Recent Development
13.7 Zydus Cadila
13.7.1 Zydus Cadila Company Details
13.7.2 Zydus Cadila Business Overview and Its Total Revenue
13.7.3 Zydus Cadila Non-Alcoholic Steatohepatitis (NASH) Treatment Introduction
13.7.4 Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
13.7.5 Zydus Cadila Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Non-Alcoholic Steatohepatitis (NASH) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue
Table 3. Ranking of Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Off-Label
Table 6. Key Players of Therapeutic
Table 7. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions (2015-2020)
Table 11. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Non-Alcoholic Steatohepatitis (NASH) Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Non-Alcoholic Steatohepatitis (NASH) Treatment Players
Table 18. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players (2015-2020)
Table 20. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2019)
Table 21. Global Non-Alcoholic Steatohepatitis (NASH) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Product Solution and Service
Table 24. Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Share by Type (2015-2020)
Table 28. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Share by Application (2015-2020)
Table 30. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 34. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 36. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 40. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 42. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 46. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 48. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 52. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 54. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 58. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 64. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 66. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share (2019-2020)
Table 70. Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application (2015-2020)
Table 74. Allergan Plc (Tobira) Company Details
Table 75. Allergan Plc (Tobira) Business Overview
Table 76. Allergan Plc (Tobira) Product
Table 77. Allergan Plc (Tobira) Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 78. Allergan Plc (Tobira) Recent Development
Table 79. Bristol Myers Squibb Company Details
Table 80. Bristol Myers Squibb Business Overview
Table 81. Bristol Myers Squibb Product
Table 82. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 83. Bristol Myers Squibb Recent Development
Table 84. Galmed Pharmaceuticals Company Details
Table 85. Galmed Pharmaceuticals Business Overview
Table 86. Galmed Pharmaceuticals Product
Table 87. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 88. Galmed Pharmaceuticals Recent Development
Table 89. Genfit SA Company Details
Table 90. Genfit SA Business Overview
Table 91. Genfit SA Product
Table 92. Genfit SA Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 93. Genfit SA Recent Development
Table 94. Gilead Sciences, Inc. Company Details
Table 95. Gilead Sciences, Inc. Business Overview
Table 96. Gilead Sciences, Inc. Product
Table 97. Gilead Sciences, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 98. Gilead Sciences, Inc. Recent Development
Table 99. Intercept Pharmaceuticals, Inc. Company Details
Table 100. Intercept Pharmaceuticals, Inc. Business Overview
Table 101. Intercept Pharmaceuticals, Inc. Product
Table 102. Intercept Pharmaceuticals, Inc. Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 103. Intercept Pharmaceuticals, Inc. Recent Development
Table 104. Zydus Cadila Company Details
Table 105. Zydus Cadila Business Overview
Table 106. Zydus Cadila Product
Table 107. Zydus Cadila Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020) (Million US$)
Table 108. Zydus Cadila Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Off-Label Features
Figure 3. Therapeutic Features
Figure 4. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Online Provider Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Non-Alcoholic Steatohepatitis (NASH) Treatment Report Years Considered
Figure 9. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Share by Players in 2019
Figure 14. Global Top Non-Alcoholic Steatohepatitis (NASH) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Alcoholic Steatohepatitis (NASH) Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis (NASH) Treatment Revenue in 2019
Figure 16. North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Allergan Plc (Tobira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Allergan Plc (Tobira) Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 25. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 27. Galmed Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 29. Genfit SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Genfit SA Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 31. Gilead Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Gilead Sciences, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 33. Intercept Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 35. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Zydus Cadila Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Treatment Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs